TY - JOUR AU - Montazeri, A. PY - 2008 DA - 2008// TI - Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007 JO - J Exp Clin Cancer Res. VL - 27 UR - https://doi.org/10.1186/1756-9966-27-32 DO - 10.1186/1756-9966-27-32 ID - Montazeri2008 ER - TY - JOUR AU - Coates, A. AU - Gebski, V. AU - Signorini, D. AU - Murray, P. AU - McNeil, D. AU - Byrne, M. PY - 1992 DA - 1992// TI - Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group JO - J Clin Oncol VL - 10 UR - https://doi.org/10.1200/JCO.1992.10.12.1833 DO - 10.1200/JCO.1992.10.12.1833 ID - Coates1992 ER - TY - JOUR AU - Albain, K. S. AU - Nag, S. M. AU - Calderillo-Ruiz, G. AU - Jordaan, J. P. AU - Llombart, A. C. AU - Pluzanska, A. PY - 2008 DA - 2008// TI - Gemcitabine plus Paclitaxel versus Paclitaxel monotherapy in patients with metastatic breast cancer and prior anthracycline treatment JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.11.9362 DO - 10.1200/JCO.2007.11.9362 ID - Albain2008 ER - TY - JOUR AU - Sledge, G. W. AU - Neuberg, D. AU - Bernardo, P. AU - Ingle, J. N. AU - Martino, S. AU - Rowinsky, E. K. PY - 2003 DA - 2003// TI - Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193) JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.08.013 DO - 10.1200/JCO.2003.08.013 ID - Sledge2003 ER - TY - JOUR AU - Sparano, J. A. AU - Wang, M. AU - Martino, S. AU - Jones, V. AU - Perez, E. A. AU - Saphner, T. PY - 2008 DA - 2008// TI - Weekly paclitaxel in the adjuvant treatment of breast cancer JO - N Engl J Med VL - 358 UR - https://doi.org/10.1056/NEJMoa0707056 DO - 10.1056/NEJMoa0707056 ID - Sparano2008 ER - TY - JOUR AU - Hershman, D. L. AU - Unger, J. M. AU - Crew, K. D. AU - Minasian, L. M. AU - Awad, D. AU - Moinpour, C. M. PY - 2013 DA - 2013// TI - Randomized double-blind placebo-controlled trial of acetyl-l-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.44.8738 DO - 10.1200/JCO.2012.44.8738 ID - Hershman2013 ER - TY - JOUR AU - Park, Y. H. AU - Jung, K. H. AU - Im, S. A. AU - Sohn, J. H. AU - Ro, J. AU - Ahn, J. H. PY - 2013 DA - 2013// TI - Phase III, multicenter, randomized trial of maintenance chemotherapy versus observation in patients with metastatic breast cancer after achieving disease control with six cycles of gemcitabine plus paclitaxel as first-line chemotherapy: KCSG-BR07-02 JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.45.2490 DO - 10.1200/JCO.2012.45.2490 ID - Park2013 ER - TY - JOUR AU - Mols, F. AU - Beijers, T. AU - Vreugdenhil, G. AU - Poll-Franse, L. PY - 2014 DA - 2014// TI - Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review JO - Support Care Cancer VL - 22 UR - https://doi.org/10.1007/s00520-014-2255-7 DO - 10.1007/s00520-014-2255-7 ID - Mols2014 ER - TY - JOUR AU - Pivot, X. AU - Marme, F. AU - Koenigsberg, R. AU - Guo, M. AU - Berrak, E. AU - Wolfer, A. PY - 2016 DA - 2016// TI - Pooled analyses of eribulin in metastatic breast cancer patients with at least one prior chemotherapy JO - Ann Oncol VL - 27 UR - https://doi.org/10.1093/annonc/mdw203 DO - 10.1093/annonc/mdw203 ID - Pivot2016 ER - TY - JOUR AU - Cortes, J. AU - O’Shaughnessy, J. AU - Loesch, D. AU - Blum, J. L. AU - Vahdat, L. T. AU - Petrakova, K. PY - 2011 DA - 2011// TI - Eribulin monotherapy versus treatment of physician’s choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study JO - Lancet VL - 377 UR - https://doi.org/10.1016/S0140-6736(11)60070-6 DO - 10.1016/S0140-6736(11)60070-6 ID - Cortes2011 ER - TY - JOUR AU - Park, Y. H. AU - Im, S. A. AU - Kim, S. B. AU - Sohn, J. H. AU - Lee, K. S. AU - Chae, Y. S. PY - 2017 DA - 2017// TI - Phase II, multicentre, randomised trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy in patients with HER2-negative metastatic breast cancer JO - Eur J Cancer VL - 86 UR - https://doi.org/10.1016/j.ejca.2017.10.002 DO - 10.1016/j.ejca.2017.10.002 ID - Park2017 ER - TY - JOUR AU - Cella, D. AU - Peterman, A. AU - Hudgens, S. AU - Webster, K. AU - Socinski, M. A. PY - 2003 DA - 2003// TI - Measuring the side effects of taxane therapy in oncology: the functional assessment of cancer therapy-taxane (FACT-taxane) JO - Cancer VL - 98 UR - https://doi.org/10.1002/cncr.11578 DO - 10.1002/cncr.11578 ID - Cella2003 ER - TY - JOUR AU - Takada, K. AU - Kashiwagi, S. AU - Fukui, Y. AU - Goto, W. AU - Asano, Y. AU - Morisaki, T. PY - 2019 DA - 2019// TI - Prognostic value of quality-of-life scores in patients with breast cancer undergoing preoperative chemotherapy JO - BJS Open. VL - 3 UR - https://doi.org/10.1002/bjs5.50108 DO - 10.1002/bjs5.50108 ID - Takada2019 ER - TY - JOUR AU - Howell, D. AU - Molloy, S. AU - Wilkinson, K. AU - Green, E. AU - Orchard, K. AU - Wang, K. PY - 2015 DA - 2015// TI - Patient-reported outcomes in routine cancer clinical practice: a scoping review of use, impact on health outcomes, and implementation factors JO - Ann Oncol VL - 26 UR - https://doi.org/10.1093/annonc/mdv181 DO - 10.1093/annonc/mdv181 ID - Howell2015 ER - TY - JOUR AU - Kawahara, M. AU - Tada, H. AU - Tokoro, A. AU - Teramukai, S. AU - Origasa, H. AU - Kubota, K. PY - 2011 DA - 2011// TI - Quality-of-life evaluation for advanced non-small-cell lung cancer: a comparison between vinorelbine plus gemcitabine followed by docetaxel versus paclitaxel plus carboplatin regimens in a randomized trial: Japan Multinational Trial Organization LC00-03 (BRI LC03-01) JO - BMC Cancer. VL - 11 UR - https://doi.org/10.1186/1471-2407-11-356 DO - 10.1186/1471-2407-11-356 ID - Kawahara2011 ER - TY - JOUR AU - Morgans, A. K. AU - Chen, Y. H. AU - Sweeney, C. J. AU - Jarrard, D. F. AU - Plimack, E. R. AU - Gartrell, B. A. PY - 2018 DA - 2018// TI - Quality of life during treatment with chemohormonal therapy: analysis of E3805 chemohormonal androgen ablation randomized trial in prostate cancer JO - J Clin Oncol VL - 36 UR - https://doi.org/10.1200/JCO.2017.75.3335 DO - 10.1200/JCO.2017.75.3335 ID - Morgans2018 ER - TY - JOUR AU - Shimozuma, K. AU - Ohashi, Y. AU - Takeuchi, A. AU - Aranishi, T. AU - Morita, S. AU - Kuroi, K. PY - 2012 DA - 2012// TI - Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial JO - Support Care Cancer VL - 20 UR - https://doi.org/10.1007/s00520-012-1492-x DO - 10.1007/s00520-012-1492-x ID - Shimozuma2012 ER - TY - JOUR AU - Postma, T. J. AU - Vermorken, J. B. AU - Liefting, A. J. AU - Pinedo, H. M. AU - Heimans, J. J. PY - 1995 DA - 1995// TI - Paclitaxel-induced neuropathy JO - Ann Oncol VL - 6 UR - https://doi.org/10.1093/oxfordjournals.annonc.a059220 DO - 10.1093/oxfordjournals.annonc.a059220 ID - Postma1995 ER - TY - JOUR AU - Lee, J. J. AU - Swain, S. M. PY - 2006 DA - 2006// TI - Peripheral neuropathy induced by microtubule-stabilizing agents JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.04.0543 DO - 10.1200/JCO.2005.04.0543 ID - Lee2006 ER - TY - JOUR AU - Wolf, S. AU - Barton, D. AU - Kottschade, L. AU - Grothey, A. AU - Loprinzi, C. PY - 2008 DA - 2008// TI - Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies JO - Eur J Cancer VL - 44 UR - https://doi.org/10.1016/j.ejca.2008.04.018 DO - 10.1016/j.ejca.2008.04.018 ID - Wolf2008 ER - TY - JOUR AU - Hershman, D. L. AU - Lacchetti, C. AU - Dworkin, R. H. AU - Lavoie Smith, E. M. AU - Bleeker, J. AU - Cavaletti, G. PY - 2014 DA - 2014// TI - Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline JO - J Clin Oncol VL - 32 UR - https://doi.org/10.1200/JCO.2013.54.0914 DO - 10.1200/JCO.2013.54.0914 ID - Hershman2014 ER - TY - JOUR AU - Smith, E. M. AU - Pang, H. AU - Cirrincione, C. AU - Fleishman, S. AU - Paskett, E. D. AU - Ahles, T. PY - 2013 DA - 2013// TI - Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial JO - JAMA VL - 309 UR - https://doi.org/10.1001/jama.2013.2813 DO - 10.1001/jama.2013.2813 ID - Smith2013 ER - TY - JOUR AU - Peter, K. AU - Martin, O. AU - Yi, H. AU - McCutcheon, S. AU - Vahdat, L. PY - 2014 DA - 2014// TI - Peripheral neuropathy (PN) in patients (pts) with metastatic breast cancer treated with eribulin: resolution and association with efficacy JO - J Clin Oncol. VL - 32 UR - https://doi.org/10.1200/jco.2014.32.26_suppl.147 DO - 10.1200/jco.2014.32.26_suppl.147 ID - Peter2014 ER - TY - JOUR AU - Song, S. J. AU - Min, J. AU - Suh, S. Y. AU - Jung, S. H. AU - Hahn, H. J. AU - Im, S. A. PY - 2017 DA - 2017// TI - Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer JO - Support Care Cancer VL - 25 UR - https://doi.org/10.1007/s00520-017-3631-x DO - 10.1007/s00520-017-3631-x ID - Song2017 ER -